On December 21, 2022, AstraZeneca Finance (08333.HK) announced that on December 21, 2022, issued and unissued shares with a face value of HK$0.01 per 10 shares were merged into 1 consolidated share with a face value of HK$0.1 per share. The company has a balance of 9.6 million shares.
阿仕特朗金融(08333.HK)"10合1"并股今日生效
AstraZeneca Financial (08333.HK) “10 in 1” stock merger takes effect today
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.